Proteome Sciences (LON:PRM) Stock Price Down 20.6% – What’s Next?

Proteome Sciences plc (LON:PRM) traded down 20.6% during trading on Monday . The stock traded as low as GBX 2.53 ($0.03) and last traded at GBX 2.53 ($0.03). 296,000 shares changed hands during trading, an increase of 32% from the average session volume of 224,490 shares. The stock had previously closed at GBX 3.18 ($0.04).

Proteome Sciences Stock Down 20.6 %

The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37. The firm has a 50-day moving average of GBX 3.74 and a 200 day moving average of GBX 3.45. The stock has a market capitalization of £7.45 million, a price-to-earnings ratio of -1.83 and a beta of 0.07.

Proteome Sciences (LON:PRM) last posted its quarterly earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.